Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 16Other hematologic neoplasm 5Lymphoid 5Genitourinary 5Gastrointestinal 4Thoracic 2Plasma cell 2Other neoplasm 2Gynecologic 2Sarcoma 1Head & Neck 1Dermatologic 1

Conditions

Uterine Cervical Neoplasms 1Radiation Injuries 1Peripheral Nervous System Diseases 1Pelvic Inflammatory Disease 1Pain 1Ovarian Neoplasms 1Neoplasms 1Breast Neoplasms 1

Interventions

Paclitaxel 581Carboplatin 528Cisplatin 359Bevacizumab 256pembrolizumab 228Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 128Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 91niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 74Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 57Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Fatty Acids, Omega-3 × Gynecologic × Clear all
NCT03994055 2025-05-25

Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer

National Institute of Cancerología

Phase NA Completed
136 enrolled
Gynecologic

Pelvic Inflammatory Disease, Uterine Cervical Neoplasms, Neoplasms, Radiation Injuries

NCT01821833 2022-10-05

Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel

New Mexico Cancer Research Alliance

Phase NA Completed
60 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pain, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡